Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor

Background. Ivacaftor improves outcomes in cystic fibrosis (CF) patients with the G551D mutation; however, effects on respiratory microbiology are largely unknown. This study examines changes in CF respiratory pathogens with ivacaftor and correlates them with baseline characteristics and clinical re...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Infect Dis
Egile Nagusiak: Heltshe, Sonya L., Mayer-Hamblett, Nicole, Burns, Jane L., Khan, Umer, Baines, Arthur, Ramsey, Bonnie W., Rowe, Steven M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2015
Gaiak:
Articles and Commentaries
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4342673/
https://ncbi.nlm.nih.gov/pubmed/25425629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciu944
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak